NEUP Projected Dividend Yield
Neuphoria Therapeutics Inc ( NASDAQ : NEUP )Bionomics Ltd is an Australia-based clinical-stage biopharmaceutical company. Co. is focused on development of novel drug candidates focused on the treatment of serious central nervous system disorders. It is developing novel allosteric ion channel modulators to treat patients suffering from serious central nervous system (CNS) disorders with high unmet medical need. It is advancing its lead drug candidate, BNC210, an oral, proprietary, selective negative allosteric modulator of the ?7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder (SAD) and chronic treatment of post-traumatic stress disorder (PTSD). 21 YEAR PERFORMANCE RESULTS |
NEUP Dividend History Detail NEUP Dividend News NEUP Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |